RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Thrombocytopenic Purpura
Accession: DOID:9005876
browse the term
Definition: Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.
Synonyms: exact_synonym: Thrombocytopenic Purpuras; Thrombopenic Purpura; Thrombopenic Purpuras
primary_id: MESH:D011696
G
Gp9
glycoprotein 9 platelet
ISO
RGD
PMID:23103637
RGD:11040532
NCBI chr 6:87,753,115...87,756,768
Ensembl chr 6:87,755,054...87,756,750
G
Itga2b
integrin alpha 2b
IDA
RGD
PMID:11493456
RGD:2316362
NCBI chr11:102,344,134...102,360,570
Ensembl chr11:102,344,123...102,360,948
G
Itgb3
integrin beta 3
IMP ISO
associated with HIV Infections
RGD
PMID:11493456 PMID:8565280
RGD:2316362 , RGD:10755471
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Vwf
Von Willebrand factor
ISO
RGD
PMID:14727254
RGD:1580644
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19260037
NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640
G
Alb
albumin
ISO
RGD
PMID:6683982
RGD:11036083
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Cd40
CD40 antigen
ISO
protein:increased expression:peripheral blood, B lymphocyte (human)
RGD
PMID:17654056
RGD:11344977
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
treatment
ISO IEP
protein:increased expression:peripheral blood, T lymphocyte (human) protein:decreased expression:serum (mouse)
RGD
PMID:17654056 PMID:22537155 PMID:18341638 PMID:16188945
RGD:11344977 , RGD:11352267 , RGD:11352237 , RGD:11344980
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cd86
CD86 antigen
treatment
ISO
protein:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:19379594 PMID:20581660
RGD:11354966 , RGD:11520785
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Dnmt3a
DNA methyltransferase 3A
ISO
mRNA:decreased expression:mononuclear cell
RGD
PMID:18683034
RGD:9588662
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
G
Dnmt3b
DNA methyltransferase 3B
susceptibility
ISO
mRNA:decreased expression:mononuclear cell DNA:SNP:promoter: -579G>T(human)
RGD
PMID:18683034 PMID:23000068
RGD:9588662 , RGD:9589094
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:serum:
RGD
PMID:10776692
RGD:11049162
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fcgr2b
Fc receptor, IgG, low affinity IIb
treatment disease_progression
ISO IMP IDA
DNA:SNP: :p.I232T (human)
RGD
PMID:21131591 PMID:21045192 PMID:22257295 PMID:15566359 PMID:19549396
RGD:11040933 , RGD:11344955 , RGD:11344931 , RGD:11344928 , RGD:11344927
NCBI chr 1:170,786,186...170,804,141
Ensembl chr 1:170,786,186...170,804,116
G
Fcgr3
Fc receptor, IgG, low affinity III
no_association susceptibility treatment
IMP ISO
DNA:SNP:cds:p.R131H (human)
RGD
PMID:20699442 PMID:23249566 PMID:22123287 PMID:21131591
RGD:11040883 , RGD:11040990 , RGD:11040989 , RGD:11040933
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
Fcgr4
Fc receptor, IgG, low affinity IV
treatment susceptibility
ISO IGI
DNA:SNP:cds:p.V158F(human) DNA:SNP:exon:p.F158V (rs396991) (human)
RGD
PMID:11380443 PMID:23484707 PMID:22123287 PMID:15479722
RGD:11040776 , RGD:11352255 , RGD:11040989 , RGD:11344926
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
Gp1ba
glycoprotein 1b, alpha polypeptide
IMP
RGD
PMID:16861348
RGD:10450841
NCBI chr11:70,529,928...70,534,812
Ensembl chr11:70,529,948...70,532,862
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
treatment
ISO
DNA:polymorphisms:cds:HLA-DQB1*0401 (human)
RGD
PMID:10435723
RGD:11041758
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Eb1
histocompatibility 2, class II antigen E beta
treatment
ISO
DNA:polymorphisms:cds:HLA-DRB1*0901, HLA-DRB1*0410 (human)
RGD
PMID:10435723
RGD:11041758
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
Il10
interleukin 10
disease_progression
ISO
DNA:SNP:promoter:-627C>A (human) DNA:SNPs, haplotypes:promoter:-1082A>G, -819C>T, -592C>A (human)
RGD
PMID:25051072 PMID:22677268
RGD:11041894 , RGD:11046267
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il18
interleukin 18
ISO
protein:increased expression:plasma:
RGD
PMID:24801815
RGD:11073600
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1a
interleukin 1 alpha
ISO
DNA:SNP:promoter:-899C>T (human)
RGD
PMID:21591983
RGD:11051966
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:repeats::
RGD
PMID:20626741
RGD:11528541
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
susceptibility
ISO
DNA:polymorphism::-330T>G(human)
RGD
PMID:20626741
RGD:11528541
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il4
interleukin 4
disease_progression
ISO
DNA:repeat:intron
RGD
PMID:25051072
RGD:11041894
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Itgb3
integrin beta 3
ISO IMP
RGD
PMID:10936026 PMID:24258817
RGD:10755473 , RGD:10755475
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Mir130a
microRNA 130a
ISO
RNA:decreased expression:PBMC
RGD
PMID:24801815
RGD:11073600
NCBI chr 2:84,571,459...84,571,522
Ensembl chr 2:84,571,459...84,571,522
G
Mir409
microRNA 409
treatment
ISO
RGD
PMID:23360331
RGD:10755694
NCBI chr12:109,709,592...109,709,670
Ensembl chr12:109,709,592...109,709,670
G
Plat
plasminogen activator, tissue
ISO
protein:increased expression:plasma (human)
RGD
PMID:2129164
RGD:11541072
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
no_association
ISO
DNA: snp: cds: C1858T DNA:snp:cds:c.1858C>T (rs2476601) (human)
RGD
PMID:21597364 PMID:27309885
RGD:6484673 , RGD:11535019
NCBI chr 3:103,763,891...103,819,568
Ensembl chr 3:103,767,111...103,819,563
G
Socs1
suppressor of cytokine signaling 1
ISO
ClinVar Annotator: match by term: Autoimmune thrombocytopenia | ClinVar Annotator: match by term: Autoimmune thrombocytopenic purpura
ClinVar
PMID:32853638 PMID:33087723
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Tgfb1
transforming growth factor, beta 1
disease_progression
ISO
mRNA:increased expression: : protein:decreased expression:plasma:
RGD
PMID:11886393 PMID:24763013 PMID:24801815
RGD:11073598 , RGD:11073603 , RGD:11073600
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Abcc2
ATP-binding cassette, sub-family member 2
susceptibility
ISO
associated with Carcinoma, Non-Small-Cell Lung;DNA:SNP, haplotype:promoter,cds: 3972C>T, -24C>T(human)
RGD
PMID:20943283
RGD:11080978
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Dpyd
dihydropyrimidine dehydrogenase
treatment
ISO
associated with Neoplasms;DNA:SNP:intron:IVS14+1G>A (human) associated with Stomach Neoplasms
RGD
PMID:19473056 PMID:23064955
RGD:11098817 , RGD:11251740
NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
G
Gstm1
glutathione S-transferase, mu 1
susceptibility treatment
ISO
associated with Ovarian Neoplasms;DNA:deletion: : (human) associated with diffuse large B-cell lymphoma; DNA:deletion:cds:
RGD
PMID:19786980 PMID:20303013
RGD:5688741 , RGD:10450835
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstt1
glutathione S-transferase, theta 1
treatment
ISO
associated with diffuse large B-cell lymphoma; DNA:deletion:cds:
RGD
PMID:20303013
RGD:10450835
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Il1a
interleukin 1 alpha
treatment
ISO
associated with Carcinoma, Non-Small-Cell Lung associated with Ovarian Neoplasms
RGD
PMID:7666093 PMID:8151314
RGD:11051963 , RGD:11051964
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
treatment
ISO
associated with Glioblastoma;
RGD
PMID:1331350
RGD:10450883
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Pecam1
platelet/endothelial cell adhesion molecule 1
severity
ISO IMP
RGD
PMID:10942385 PMID:17234740
RGD:11541093 , RGD:11541120
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pf4
platelet factor 4
treatment
ISO
RGD
PMID:31863655
RGD:329901923
NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
G
Fcgr4
Fc receptor, IgG, low affinity IV
susceptibility
ISO
DNA:SNP:cds:p.V158F(human)
RGD
PMID:15191947
RGD:11040991
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
Il10
interleukin 10
no_association
ISO
DNA:repeats, haplotype:promoter DNA:SNPs:promoter:rs1800896 (-1082G/A), rs1800871 (-819C/T), rs1800872 (-592C/A) (human)
RGD
PMID:22239992 PMID:22239992
RGD:11049164 , RGD:11049164
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Itgb3
integrin beta 3
ISO
ClinVar Annotator: match by term: PEN(a)/PEN(b) ALLOANTIGEN POLYMORPHISM
ClinVar OMIM
PMID:1430225 PMID:9787162 PMID:14516468 PMID:21658138 PMID:25741868 PMID:28492532 More...
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO IMP
ClinVar Annotator: match by term: ADAMTS13-related condition | ClinVar Annotator: match by term: Thrombotic thrombocytopenic purpura | ClinVar Annotator: match by term: Upshaw-Schulman syndrome CTD Direct Evidence: marker/mechanism Adult Onset Purpura, Thrombotic Thrombocytopenic;DNA:missense mutation:cds:p.R1060W (human) DNA:mutations:multiple (human) protein:decreased activity:plasma (human)
OMIM ClinVar CTD RGD
PMID:1787257 PMID:6433703 PMID:7094941 PMID:9536098 PMID:11563771 PMID:11586351 PMID:12181489 PMID:12393505 PMID:12434890 PMID:12576319 PMID:12614216 PMID:12656756 PMID:12753286 PMID:14512317 PMID:14563640 PMID:14597993 PMID:15009458 PMID:15126318 PMID:15521921 PMID:15800115 PMID:16160007 PMID:16199547 PMID:16388417 PMID:16453338 PMID:16597588 PMID:16796708 PMID:16807643 PMID:17003922 PMID:17187257 PMID:17576681 PMID:17627784 PMID:17849048 PMID:18031293 PMID:18443791 PMID:18481107 PMID:18581589 PMID:18665921 PMID:19047683 PMID:19055667 PMID:19786614 PMID:19847791 PMID:20647566 PMID:20886194 PMID:21488199 PMID:21676167 PMID:21781265 PMID:22289888 PMID:22529288 PMID:22547583 PMID:22768050 PMID:22783805 PMID:23058857 PMID:23208954 PMID:23346910 PMID:23621748 PMID:23648131 PMID:23715102 PMID:23847193 PMID:23878316 PMID:24033266 PMID:24115559 PMID:24433405 PMID:24859360 PMID:24936513 PMID:25442981 PMID:25741868 PMID:25934476 PMID:26081109 PMID:26139087 PMID:26342041 PMID:26352112 PMID:26566785 PMID:27132698 PMID:27427187 PMID:27802307 PMID:28492532 PMID:28678087 PMID:28748566 PMID:28866379 PMID:29554699 PMID:29763513 PMID:30046676 PMID:30312976 PMID:30762934 PMID:30792199 PMID:31064749 PMID:31971692 PMID:31980526 PMID:32183147 PMID:32496441 PMID:34355501 PMID:35022991 PMID:18031293 PMID:11586351 PMID:16200209 PMID:9129011 More...
RGD:10449043 , RGD:1598736 , RGD:10449037 , RGD:10449028
NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640
G
Cd36
CD36 molecule
ISO
RGD
PMID:7529543
RGD:11041104
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
F3
coagulation factor III
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7740478
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
ISO
DNA:polymorphisms:cds:HLA-DQB1*0301 (human)
RGD
PMID:19922436
RGD:11041754
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
Proc
protein C
ISO
RGD
PMID:10936861
RGD:11100014
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7740478 PMID:7740478
RGD:11340214
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7740478
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
treatment
ISO
human protein in a rat model
RGD
PMID:9828246 PMID:26338302
RGD:10449039 , RGD:10449097
NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640
G
Vwf
Von Willebrand factor
treatment
ISO
RGD
PMID:26863353
RGD:11079195
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all